US2011020822A1PendingUtilityA1
Molecular detection of chromosome aberrations
Assignee: ERAMUS UNIVERSITEIT ROTTERDAMPriority: May 13, 1997Filed: Jul 20, 2010Published: Jan 27, 2011
Est. expiryMay 13, 2017(expired)· nominal 20-yr term from priority
C12Q 1/6886C12Q 2600/156C12Q 1/6841C12Q 1/6876
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the field of cytogenetics and the application of genetic diagnostic techniques in pathology and hematology. Specifically, the invention relates to nucleic acid probes that can be used in hybridization techniques for the detection of chromosomal aberrations and other gene rearrangements such as immunoglobulin and T-cell receptor gene rearrangements. The probes provided by the invention are a distinct and balanced set of probes of comparable size, each preferably being from 1 to 100 kb, or smaller, and flanking a potential breakpoint in a chromosome.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A pair of nucleic acid probes for the detection of at least one chromosomal aberration involving a chromosomal breakpoint in interphase nuclei by in situ hybridization,
wherein each of the nucleic acid probes is made up of multiple oligonucleotides, wherein each of the nucleic acid probes is labeled directly with at least one different reporter molecule, wherein each of the nucleic acid probes hybridizes to a sequence such that the pair of nucleic acid probes flank the chromosomal breakpoint cluster region upon hybridization to the chromosome, wherein the nucleic acid probes hybridize at a genomic distance resulting in colocalization of the reporter molecule signals if no chromosome aberration is present, and wherein the probes detect one or more of the following aberrations: t(1;19), t(2;5), t(2;8), t(2;18), t(4;11), t(8;14), t(8;22), t(9;22), t(11;14), t(12;21), t(14;18), t(18;22), t(1;11)(q21;q23), t(1;11)(p32;q23), t(2;11)(p21;q23), t(2;18)(p12;q21), t(4;11)(q21;q23), t(6;11)(q27;q23), t(7;22)(p22;q12), t(9;11)(p22;q23), t(11;19)(q23;p13), t(11;22)(q24;q21), t(14;18)(q23;q21), t(14;18)(q32;q21), t(18;22)(q21;q11), or t(21;22)(q22;q12).
18 . A pair of nucleic acid probes according to claim 17 , wherein the at least one different reporter molecule comprises at least one chromophore.
19 . A pair of nucleic acid probes according to claim 18 , wherein each of the nucleic acid probes is larger than 25 kb.
20 . A pair of nucleic acid probes according to claim 17 , wherein the pair of nucleic acid probes are labeled with the at least one reporter molecule resulting in signals of comparable intensity between the pair of nucleic acid probes.
21 . A pair of nucleic acid probes according to claim 17 , wherein the combination of relative size of each of the nucleic acid probes, intensity of the at least one reporter molecule labeling each of the nucleic acid probes, and genomic distance between each of the nucleic acid probes following hybridization to the chromosome, results in signals from the nucleic acid probes of comparable intensity.
22 . A pair of nucleic acid probes according to claim 17 , wherein there is no overlap of the pair of nucleic acid probes with the breakpoint cluster region of the chromosome.
23 . A pair of nucleic acid probes according to claim 17 , wherein each of the nucleic acid probes does not contain major repetitive sequences.
24 . A pair of nucleic acid probes according to claim 17 , wherein the pair of nucleic acid probes hybridizes to a single corresponding nucleic acid molecule.
25 . A pair of nucleic acid probes according to claim 24 , wherein the corresponding nucleic acid molecule is at least a fragment of a chromosome.
26 . A pair of nucleic acid probes for the detection of at least one chromosomal aberration involving a chromosomal breakpoint in interphase nuclei by in situ hybridization,
wherein each of the nucleic acid probes is made up of multiple oligonucleotides, wherein each of the nucleic acid probes is larger than 25 kb, wherein each of the nucleic acid probes is labeled directly with at least one different reporter molecule, wherein the at least one different reporter molecule comprises at least one chromophore, wherein each of the nucleic acid probes hybridizes to a sequence such that the pair of nucleic acid probes flank the chromosomal breakpoint cluster region upon hybridization to the chromosome, wherein the nucleic acid probes hybridize at a genomic distance resulting in colocalization of the reporter molecule signals if no chromosome aberration is present and wherein the probes detect one or more of the following aberrations: t(1;19), t(2;5), t(2;8), t(2;18), t(4;11), t(8;14), t(8;22), t(9;22), t(11;14), t(12;21), t(14;18), t(18;22), t(1;11)(q21;q23), t(1;11)(p32;q23), t(2;11)(p21;q23), t(2;18)(p12;q21), t(4;11)(q21;q23), t(6;11)(q27;q23), t(7;22)(p22;q12), t(9;11)(p22;q23), t(11;19)(q23;p13), t(11;22)(q24;q21), t(14;18)(q23;q21), t(14;18)(q32;q21), t(18;22)(q21;q11), or t(21;22)(q22;q12).
27 . A pair of nucleic acid probes according to claim 26 , wherein the pair of nucleic acid probes are labeled with the at least one reporter molecule resulting in signals of comparable intensity between the pair of nucleic acid probes.
28 . A pair of nucleic acid probes according to claim 26 , wherein the combination of relative size of each of the nucleic acid probes, intensity of the at least one reporter molecule labeling each of the nucleic acid probes, and genomic distance between each of the nucleic acid probes following hybridization to the chromosome, results in signals from the nucleic acid probes of comparable intensity.
29 . A pair of nucleic acid probes according to claim 26 , wherein there is no overlap of the pair of nucleic acid probes with the breakpoint cluster region of the chromosome.
30 . A pair of nucleic acid probes according to claim 26 , wherein each of the nucleic acid probes does not contain major repetitive sequences.
31 . A pair of nucleic acid probes according to claim 26 , wherein the pair of nucleic acid probes hybridizes to a single corresponding nucleic acid molecule.
32 . A pair of nucleic acid probes according to claim 31 , wherein the corresponding nucleic acid molecule is at least a fragment of a chromosome.
33 . A diagnostic kit comprising at least a pair of nucleic acid probes for the detection of at least one chromosomal aberration involving a chromosomal breakpoint in interphase nuclei by in situ hybridization,
wherein each of the nucleic acid probes is made up of multiple oligonucleotides, wherein each of the nucleic acid probes is labeled directly with at least one different reporter molecule, wherein each of the nucleic acid probes hybridizes to a sequence such that the pair of nucleic acid probes flank the chromosomal breakpoint cluster region upon hybridization to the chromosome, wherein the nucleic acid probes hybridize at a genomic distance resulting in colocalization of the reporter molecule signals if no chromosome aberration is present and wherein the probes detect one or more of the following aberrations: t(1;19), t(2;5), t(2;8), t(2;18), t(4;11), t(8;14), t(8;22), t(9;22), t(11;14), t(12;21), t(14;18), t(18;22), t(1;11)(q21;q23), t(1;11)(p32;q23), t(2;11)(p21;q23), t(2;18)(p12;q21), t(4;11)(q21;q23), t(6;11)(q27;q23), t(7;22)(p22;q12), t(9;11)(p22;q23), t(11;19)(q23;p13), t(11;22)(q24;q21), t(14;18)(q23;q21), t(14;18)(q32;q21), t(18;22)(q21;q11), or t(21;22)(q22;q12).
34 . A method for the detection of at least one chromosomal aberration involving a chromosomal breakpoint in interphase nuclei by in situ hybridization, said method comprising:
providing a pair of nucleic acid probes,
wherein each of the nucleic acid probes is made up of multiple oligonucleotides,
each of the nucleic acid probes is labeled directly with at least one different reporter molecule,
each of the nucleic acid probes hybridizes to a sequence such that the pair of nucleic acid probes flank the chromosomal breakpoint upon hybridization to the chromosome, and
the nucleic acid probes hybridize at a genomic distance resulting in colocalization of the reporter molecule signals if no chromosome aberration is present;
and either
detecting colocalization of the reporter molecule signals indicating that no chromosomal aberration is present,
or
detecting two separate reporter molecule signals indicating that a chromosomal aberration is present.
35 . A method for the detection of at least one chromosomal aberration involving a chromosomal breakpoint in interphase nuclei by in situ hybridization, said method comprising:
providing a pair of nucleic acid probes, wherein each of the nucleic acid probes is made up of multiple oligonucleotides, each of the nucleic acid probes is larger than 25 kb, each of the nucleic acid probes is labeled directly with at least one different reporter molecule, the at least one different reporter molecule comprises at least one chromophore, each of the nucleic acid probes hybridizes to a sequence such that the pair of nucleic acid probes flank the chromosomal breakpoint upon hybridization to the chromosome, and wherein the nucleic acid probes hybridize at a genomic distance resulting in colocalization of the reporter molecule signals if no chromosome aberration is present;
and either
detecting colocalization of the reporter molecule signals indicating that no chromosomal aberration is present,
or
detecting two separate reporter molecule signals indicating that a chromosomal aberration is present.Join the waitlist — get patent alerts
Track US2011020822A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.